Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New walking program with blood flow cuffs shows promise for kids with cerebral palsy

NCT ID NCT06533956

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether a 10-week treadmill training program combined with blood flow restriction (using cuffs on the legs) can safely improve walking speed in 13 children aged 8 to 18 with cerebral palsy. The children will walk on a treadmill three times a week, gradually increasing speed. The goal is to see if this approach is feasible and effective for boosting walking ability and muscle strength.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
blood flow restriction during treadmill training
What this could lead to
If it works, this could offer a more efficient way to improve walking ability in children with cerebral palsy, potentially reducing therapy time and costs.
What could go wrong
This is a very small pilot study with only 13 children, so results may not apply to everyone. The intervention is experimental and may not lead to significant improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 13 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2024

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

8 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 8 to 18 with bilateral spastic cerebral palsy * Patient with functional level II or III according to the Gross Motor Function Classification System (GMFCS) * Patient able to assess pain with NRS-11 * Patient able to walk on a treadmill without body weight support, with or without technical aids * Patient able to perform the 10-meter walk test * No skin pathology at the pressure cuff application site (eczema, inflammatory scarring, etc.) * Patient affiliated to or benefiting from a social security scheme * Informed consent, dated and signed by parents or guardians (if a minor) or by the patient (if of age), to participate in the study; Exclusion Criteria: * Patients who have undergone surgical treatment or intramuscular injections of botulinum toxin in the lower limbs within the last 3 months * Patients with a history of arterial hypertension, thrombo-embolic events, thrombophilia or cancer. * Patient with insufficient understanding of the French language; * Opposition of the patient (child or adolescent); * Pregnant, breast-feeding or parturient women; * Persons deprived of their liberty by judicial or administrative decision; * Persons under compulsory psychiatric care; * Persons under legal protection

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bilateral spastic cerebral palsy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Les Capucins

    RECRUITING

    Angers, France

  • University Hospital, Angers

    NOT_YET_RECRUITING

    Angers, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.